Intermediate term results for iodine 125 brachytherapy for favourable risk prostate cancer for 556 patients

被引：0
|
作者：
Crook, J. [1 ]
Yeung, I. [1 ]
Gillan, C. [1 ]
McLean, M. [1 ]
Lockwood, G. [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 80卷
关键词：
D O I：
10.1016/S0167-8140(06)80883-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
142
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [31] HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer
    Moreno Olmedo, E.
    Nagore, G.
    Suarez Gironzini, V.
    Minguez, C.
    Gomez, E.
    Garcia, A.
    Ciapa, V.
    Marrone, I.
    Lopez, E.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1122 - S1123
  • [32] HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer
    Moreno Olmedo, E.
    Nagore, G.
    Suarez-Gironzini, V.
    Minguez, C.
    Gomez, E.
    Garcia, A.
    Ciapa, V.
    Marrone, I.
    Lopez, E.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S123 - S123
  • [33] I-125 brachytherapy in low/intermediate risk prostate cancer according with NCCN and EAU guidelines
    Trigo, M. L.
    Fernandes, P.
    Garcia, S.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1616 - S1617
  • [34] IODINE 125 BRACHYTHERAPY FOR PROSTATE CANCER IN RAVENNA, EVALUATION OF THE QUALITY OF LIFE (QOL)
    del Duca, M.
    Teodorani, N.
    Palazzi, S.
    Ermanno, E.
    Minguzzi, N.
    Biagini, M. C.
    Di Stefano, C.
    Voce, S.
    Mazzotti, G.
    Morelli, M.
    Mascia, M. P.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S217 - S218
  • [35] Deposition of Iodine-125 on Silver Supports of Microsources for Prostate Cancer Brachytherapy
    Shapovalov, V. V.
    Artamonov, S. A.
    Eldashev, N. V.
    Kutin, A. Yu.
    Nerozin, N. A.
    Podsoblyaev, D. A.
    Samsonov, M. D.
    Togaeva, N. R.
    Tkachev, S. V.
    RADIOCHEMISTRY, 2022, 64 (05) : 641 - 644
  • [36] Deposition of Iodine-125 on Silver Supports of Microsources for Prostate Cancer Brachytherapy
    V. V. Shapovalov
    S. A. Artamonov
    N. V. Eldashev
    A. Yu. Kutin
    N. A. Nerozin
    D. A. Podsoblyaev
    M. D. Samsonov
    N. R. Togaeva
    S. V. Tkachev
    Radiochemistry, 2022, 64 : 641 - 644
  • [37] Permanent iodine 125 implant brachytherapy in localized prostate cancer: results of the first 4 years of experience.
    Bladou, F
    Salem, N
    Simonian-Sauve, M
    Rosello, R
    Ternier, F
    Resbeut, M
    Alzieu, C
    Karsenty, G
    Serment, G
    Gravis, G
    Maraninchi, D
    PROGRES EN UROLOGIE, 2004, 14 (03): : 345 - 352
  • [38] 125-IODINE PROSTATE BRACHYTHERAPY (BT) AS MONOTHERAPY IN PATIENTS AGED 55 YEARS OR LESS WITH LOCALIZED PROSTATE CANCER
    Gomez-Iturriaga, A.
    Crook, J.
    Lockwood, G.
    Fleshner, N.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S1 - S1
  • [39] Localized prostate cancer with intermediate- or high-risk features treated with combined external beam radiotherapy and iodine-125 seed brachytherapy
    da Silva Franca, Carlos Antonio
    Vieira, Sergio L.
    Carvalho, Antonio Carlos P.
    Bernabe, Antonio Jose S.
    Penna, Antonio Belmiro Rodrigues C.
    BRACHYTHERAPY, 2010, 9 (04) : 307 - 312
  • [40] Validation and comparison of the two Kattan nomograms in patients with prostate cancer treated with 125iodine brachytherapy
    Kaplan, Alan
    German, Larissa
    Chen, Juza
    Matzkin, Haim
    Mabjeesh, Nicola J.
    BJU INTERNATIONAL, 2012, 109 (11) : 1661 - 1665
12345